Shambhavi S, Singh H, Ramaprasad G, Khikmatov M, Vankeshwaram V, Ashish K, et al. Efficacy of Infliximab Versus Vedolizumab in the Management of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review and Meta-Analysis. World J Oncol [Internet]. 2025 Jan. 1 [cited 2026 Jan. 2];16(4):331-4. Available from: https://wjon.elmerpub.com/wjon/article/view/2613